Beleave Inc
CSE:BE
As At 11/25/2107
Shares Outstanding: 532,416,754
Share Price: $1.73 Market Cap: $32,416,754
VIEW CASE STUDY LINKS HERE
Of note, Quinsam Capital Corporation (CSE: QCA) recently announced $6.758 million in new investments, which includes $343,000 in HVT at $1.82 per share, viewing the stock as “undervalued at this time and happy with maintaining the position”.
The company is taking a significant risk with going the outdoor grow route, however, if regulations allow for it, HVT is poised to take the lead in British Columbia on extraction grade cannabis and become a major player with low cost production in Canada, and inroads already into Europe and Australia with Satipharm could make it a very viable global player in this sector.
Keep in mind that our case studies are designed to bring a greater awareness of specific or groups of companies for the typical retail investor to consider further analysis and due diligence on. Case studies such as this one are not meant to be investment advice or a recommendation.
265
Source: CIBC Investor’s Edge, Stock Centre
Spiro Sertsis, CPA, CMA
@SpiroSertsis